TCL Archive Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers June 26, 2009
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC March 11, 1977
TCL Archive In Brief: Chabner Says John Antoine Of New Mexico May Head radiation Program; GM Winners Announced June 14, 1985
TCL Archive ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children January 30, 2004
